Tacrolimus with mycophenolate mofetil or sirolimus compared with calcineurin inhibitor-free immunosuppression (sirolimus/mycophenolate mofetil) after heart transplantation: 5-year results

Journal of Heart and Lung Transplantation

Volumn 32, Issue 3, 2013, Pages 277-284

  Kaczmarek, Ingo ^a,b   Zaruba, Marc Michael ^a   Beiras Fernandez, Andres ^c   Reimann, Ricarda ^a   Nickel, Thomas ^a   Grinninger, Carola ^a   Sadoni, Sebastian ^a   Hagl, Christian ^b   Meiser, Bruno ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c GOETHE UNIVERSITY   (Germany)

Author keywords

calcineurin inhibitor free immunosuppression; cardiac allograft vasculopathy; mammalian target of rapamycin (mTOR) inhibitor; tacrolimus

Indexed keywords

METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; CARDIAC GRAFT REJECTION; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEART TRANSPLANTATION; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STEROID THERAPY; SURVIVAL; VASCULAR DISEASE;

DRUG THERAPY, COMBINATION; FEMALE; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; SIROLIMUS; TACROLIMUS; TIME FACTORS;

EID: 84873885509     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2012.11.028     Document Type: Article

References (17)

1. G.L. Plosker, and R.H. Foster Tacrolimus: a further update of its pharmacology and therapeutic use in the management of organ transplantation Drugs 59 2000 323 389
2. T.E. Starzl, S. Todo, J. Fung, A.J. Demetris, R. Venkataramman, and A. Jain Fk 506 for liver, kidney, and pancreas transplantation Lancet 2 1989 1000 1004
3. B.M. Meiser, J. Groetzner, and I. Kaczmarek Tacrolimus or cyclosporine: Which is the better partner for mycophenolate mofetil in heart transplant recipients? Transplantation 78 2004 591 598
4. M.C. Villarroel, M. Hidalgo, and A. Jimeno Mycophenolate mofetil: an update Drugs Today (Barc) 45 2009 521 532
5. A. Keogh, M. Richardson, and P. Ruygrok Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years: a randomized clinical trial Circulation 110 2004 2694 2700
6. H.J. Eisen, E.M. Tuzcu, and R. Dorent Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients N Engl J Med 349 2003 847 858
7. J. Groetzner, B. Meiser, and P. Landwehr Mycophenolate mofetil and sirolimus as calcineurin inhibitor-free immunosuppression for late cardiac-transplant recipients with chronic renal failure Transplantation 77 2004 568 574
8. J. Groetzner, I. Kaczmarek, and U. Schulz Investigators VE. Mycophenolate and sirolimus as calcineurin inhibitor-free immunosuppression improves renal function better than calcineurin inhibitor-reduction in late cardiac transplant recipients with chronic renal failure Transplantation 87 2009 726 733
9. M.I. Hertz, D.O. Taylor, and E.P. Trulock The registry of the international Society for Heart and Lung Transplantation. All rights reserved.: Nineteenth official report-2002 J Heart Lung Transplant 21 2002 950 970
10. B. Meiser, I. Kaczmarek, and M. Mueller Low-dose tacrolimus/sirolimus and steroid withdrawal in heart recipients is highly efficacious J Heart Lung Transplant 26 2007 598 603
11. B.M. Keck, L.E. Bennett, J. Rosendale, O.P. Daily, R.J. Novick, and J.D. Hosenpud Worldwide thoracic organ transplantation: a report from the UNOS/ISHLT international registry for thoracic organ transplantation Clin Transpl 1999 35 49
12. R.K. Avery Viral triggers of cardiac-allograft dysfunction N Engl J Med 344 2001 1545 1547
13. J.A. Kobashigawa, L.W. Miller, and S.D. Russell First R, Study I. Tacrolimus with mycophenolate mofetil (MMF) or sirolimus vs. Cyclosporine with MMF in cardiac transplant patients: 1-year report Am J Transplant 6 2006 1377 1386
14. D. Schmauss, and M. Weis Cardiac allograft vasculopathy: recent developments Circulation 117 2008 2131 2141
15. I. Kaczmarek, B. Ertl, and D. Schmauss Preventing cardiac allograft vasculopathy: Long-term beneficial effects of mycophenolate mofetil J Heart Lung Transplant 25 2006 550 556
16. B. Reichart, B. Meiser, and M. Vigano European multicenter tacrolimus (FK506) heart pilot study: one-year results - European Tacrolimus Multicenter Heart Study Group J Heart Lung Transplant 17 1998 775 781
17. B.M. Meiser, P. Uberfuhr, and A. Fuchs Single-center randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of acute myocardial rejection J Heart Lung Transplant 17 1998 782 788